Additional European Equity News

Bayer (BAYN GY) - Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies. (Bayer)

GSK (GSK LN) - Shingrix fully liquid accepted for US FDA review; FDA decision on application exp. by 20 June 2025. (Newswires) 

Nordex (NDX1 GY) - PPC Renewables places three orders with the Co. totalling 100 MW nominal capacity in Greece. (Newswires) 

Luxury Names - Prada (1913 HK) is reportedly among potential buyers considering the acquisition of Versace, which Capri Holdings (CPRI) has put up for sale, following Tapestry's (TPR) abandoned USD 8.5bln deal for Capri in November 2024. (Il Sole 24)

Segro (SGRO LN) - Selp JV prices EUR 500mln 3.75% unsecured bond. (Newswires) 

Sainsbury's (SBRY LN) - Q3 Trading Statement: Total Retail (ex-fuel) 2.7% (prev. 6.5% Y/Y), Total Retail (inc. fuel) 0.0% (prev. 4.4%); Guides FY retail underlying profit in line with consensus and midpoint of forecasts; will raise hourly pay by 5%. (Newswires) 

Vodafone (VOD LN) - Indus Tower stake sale; placing raises USD 330mln and repays USD 105mln in borrowing. Used proceeds from capital raise to pay outstanding master service agreement dues to Indus. (Newswires) 

EDP (EDP PL) downgraded to Equal Weight from Overweight at Barclays 

Croda (CRDA LN) downgraded to Equal Weight from Overweight at Morgan Stanley 

Haleon (HLN LN) downgraded to Equal Weight from Overweight at Morgan Stanley